ATA

ATRAZINE GLUTATHIONE CONJUGATE

Created:	1999-07-08
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where ATA is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	63
Chiral Atom Count	2
Bond Count	63
Aromatic Bond Count	6

2D diagram of ATA

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	ATRAZINE GLUTATHIONE CONJUGATE
Systematic Name (OpenEye OEToolkits)	(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[[4-ethylamino-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]sulfanyl]-1-oxo-propan-2-yl]amino]-5-oxo-pentanoic acid
Formula	C₁₈ H₃₀ N₈ O₆ S
Molecular Weight	486.546
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(O)C(N)CCC(=O)NC(C(=O)NCC(=O)O)CSc1nc(nc(n1)NC(C)C)NCC
SMILES	CACTVS	3.341	CCNc1nc(NC(C)C)nc(SC[CH](NC(=O)CC[CH](N)C(O)=O)C(=O)NCC(O)=O)n1
SMILES	OpenEye OEToolkits	1.5.0	CCNc1nc(nc(n1)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)NC(C)C
Canonical SMILES	CACTVS	3.341	CCNc1nc(NC(C)C)nc(SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)n1
Canonical SMILES	OpenEye OEToolkits	1.5.0	CCNc1nc(nc(n1)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)NC(C)C
InChI	InChI	1.03	InChI=1S/C18H30N8O6S/c1-4-20-16-24-17(22-9(2)3)26-18(25-16)33-8-11(14(30)21-7-13(28)29)23-12(27)6-5-10(19)15(31)32/h9-11H,4-8,19H2,1-3H3,(H,21,30)(H,23,27)(H,28,29)(H,31,32)(H2,20,22,24,25,26)/t10-,11-/m0/s1
InChIKey	InChI	1.03	WDLCRTLULMGVMR-QWRGUYRKSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB02146
Name	Glutathione S-atrazine
Groups	experimental
Synonyms	Glutathione S-atrazine Atrazine glutathione conjugate
CAS number	24429-05-8

Related Resource References

Resource Name	Reference
PubChem	5287712

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.